Seminars in Radiation Oncology
Volume 19, Issue 4 , Pages 236-243 , October 2009

Postmastectomy Radiation Therapy for Patients With Locally Advanced Breast Cancer

  • Reshma Jagsi, MD, DPhil

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Reshma Jagsi, MD, DPhil, Department of Radiation Oncology, UHB2C490, SPC 5010, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5010
    • ,
  • Lori Pierce, MD

References 

  1. American Joint Committee on Cancer: AJCC: Cancer staging Manuals (eds 1-5). Chicago, IL, AJCC
  2. American Joint Committee on Cancer: AJCC. Cancer Staging Manual and Handbook. (ed 6). Chicago, IL: AJCC; 2002;
  3. Clarke M, Collins R, Darby S, et al. Early Breast Cancer Trialists' Collaborative Group Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  4. McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg. 1986;73:264–266
  5. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol. 1987;5:1546–1555
  6. Velez-Garcia E, Carpenter JT, Moore M, et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) trial. Eur J Cancer. 1992;28A:1833–1837
  7. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447–453
  8. Olson JE, Neuberg D, Pandya KJ, et al. The role of radiotherapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer. 1997;79:1138–1149
  9. Fowble B. Postmastectomy radiation: A modest benefit prevails for high risk patients. Cancer. 1997;79:1061–1066
  10. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–126
  11. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy (Danish Breast Cancer Cooperative Group 82b Trial). N Engl J Med. 1997;337:949–955
  12. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  13. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–1700
  14. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol. 2004;22:4247–4254
  15. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  16. Ceilley E, Jagsi R, Goldberg S, et al. Radiotherapy for invasive breast cancer in North America and Europe: Results of a survey. Int J Radiat Oncol Biol Phys. 2005;61:365–373
  17. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended by international consensus reports? (A subgroup analysis of the DBCG 82 b & c randomized trials). Radiother Oncol. 2007;82:247–253
  18. Mignano JE, Gage I, Piantadosi S, et al. Local recurrence after mastectomy in patient with T3N0 breast carcinoma treated without postoperative irradiation. Breast Cancer Res Treat. 1996;41:255;(abst)
  19. Helinto M, Blomqvist C, Heikkila P, et al. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: Is it needed?. Radiother Oncol. 1999;52:213–217
  20. Floyd SR, Buchholz TA, Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006;66:358–364
  21. Taghian AG, Jeong JH, Mamounas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: Results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol. 2006;24:3927–3932
  22. Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: Results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol. 2003;21:1205–1213
  23. Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: Implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035–1039
  24. Truong PT, Lesperance M, Culhaci A, et al. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys. 2005;62:175–182
  25. Medical Research Council. SUPREMO trial. http://www.supremo-trial.com/index.htmlAccessed January 13, 2009
  26. Huang EH, Tucker SL, Strom EA, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004;22:4691–4699
  27. Huang EH, Tucker SL, Strom EA, et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:351–357
  28. Mamounas EP, Wang J, Bryant J, et al. Patterns of loco-regional failure in patients receiving neoadjuvant chemotherapy: Results from NSABP B18. Breast Cancer Res Treat. 2003;82:S17;(abstr 35)
  29. Mamounas E: Sentinel node biopsy after neoadjuvant chemotherapy: The pros: Presented at Preoperative Therapy in Invasive Breast Cancer: Reviewing the State of the Science and Exploring New Research Directions. National Cancer Institute. Bethesda, MD, March 26, 2007
  30. Buchholz TA, Lehman CD, Harris JR, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference. J Clin Oncol. 2008;26:791–797
  31. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  32. Harris JR, Halpin-Murphy P, McNeese M, et al. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:989–990
  33. Taylor ME, Haffty BG, Shank BM, et al. Postmastectomy radiotherapy; American College of Radiology, ACR: Appropriateness criteria. Radiology. 2000;215(suppl):1153–1170
  34. Truong PT, Olivotto NA, Whelan TJ, et al. Clinical practice guidelines for the care and treatment of breast cancer. 16. Locoregional post-mastectomy radiotherapy. CMAJ. 2004;170:1263–1273

PII: S1053-4296(09)00046-0

doi: 10.1016/j.semradonc.2009.05.009

Seminars in Radiation Oncology
Volume 19, Issue 4 , Pages 236-243 , October 2009

Article Tools

* Image Usage & Resolution